[Secondary metastatic neuromeningeal localization of neuroblastoma in children]

P Rohrlich1, O Hartmann, D Couanet

  • 1Département de Pédiatrie, Institut Gustave-Roussy, Villejuif.

Archives Francaises De Pediatrie
|January 1, 1989
PubMed

Insights

Central nervous system (CNS) metastases are rare in pediatric neuroblastoma, affecting 2.7% of patients. These metastases, particularly meningeal involvement, are associated with a poor prognosis and rapid disease progression.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Metastasis

Background:

  • Neuroblastoma is a common pediatric malignancy.
  • Central nervous system (CNS) metastases in neuroblastoma are infrequently studied.
  • Understanding the characteristics of CNS metastases is crucial for prognosis.

Observation:

  • A study of 258 children with neuroblastoma identified CNS metastases in 7 patients (2.7%).
  • Parenchymal involvement occurred later (mean 21 months) and signaled relapse, even with local treatment.
  • Meningeal involvement (3 cases) presented earlier (mean 12.7 months) and led to rapid mortality.

Findings:

  • Clinical presentation in children differs from adults, with rapid symptom onset and frequent intracranial hypertension.
  • Computed Tomography (CT) scans are valuable for diagnosing CNS metastases.
  • Literature review of 30 reported cases indicates a worse prognosis for CNS neuroblastoma metastases.

Implications:

  • Early detection and management strategies for CNS metastases are needed.
  • The distinct clinical course in children warrants specific research focus.
  • Improved understanding may lead to better therapeutic approaches and outcomes for pediatric neuroblastoma patients with CNS involvement.

Related Concept Videos